Finpresso Finpresso
Expert Guide

The Best Stock Screeners in 2026

Tools for turning nine thousand tickers into a shortlist you can actually research.

LC
Louis CorneloupFounder, Dupple · 930,000+ readers · Updated Sep 2026
Product links may be affiliate links. How we rate 5 tools compared
TL;DR

The best stock screeners in 2026 are TradingView for charting plus screening in one place, Finviz for the fastest free visual screen, Stock Rover for deep fundamental and portfolio analysis, Koyfin for institutional-grade data at a retail price, and Zacks if you want ranked estimate revisions rather than raw filters. Start free: three of these are genuinely usable at zero cost.

This is a comparison of research tools, not investment advice. Nothing here is a recommendation to buy or sell any security.

Key facts5 tools compared: TradingView, Finviz, Stock Rover, Koyfin, Zacks
  • Updated: September 25, 2026
  • Top pick: TradingView (best for: Investors who want screening and charting in one tool)
  • Top pick price as of September 25, 2026: TradingView: From $12.95/mo billed annually (Essential); free plan ($0)
  • 5 tools compared: TradingView, Finviz, Stock Rover, Koyfin, Zacks
  • Finviz (best for: The fastest free screen on US equities): Free tier with delayed data; Elite $39.50/mo or $299.95/yr
  • Stock Rover (best for: Deep fundamental analysis and portfolio work): Free tier; Premium $29/mo, Premium Plus $49/mo, Ultimate $79/mo; 14-day trial
  • Koyfin (best for: Institutional-style data on a retail budget): Free tier; Plus $39/mo, Premium $79/mo; annual billing saves up to 30%

A screener does one job: reduce a universe of thousands of listed companies to a handful worth reading about. Everything after that is your work. The tools differ on which filters they expose, how far back the data goes, whether you can test an idea historically, and how much of it survives on the free tier.

Pick based on whether you think in charts, in financial statements, or in estimate revisions.

Research tooling comparison only. This is not investment advice and none of these tools should be treated as a recommendation.

Top Picks

Based on features, real-world fit, and value for money.

Best Stock Screeners in 2026: 5 tools compared, updated Sep 2026
ToolPricingBest for
TradingViewFrom $12.95/mo billed annually (Essential); free plan ($0)Investors who want screening and charting in one tool
FinvizFree tier with delayed data; Elite $39.50/mo or $299.95/yrThe fastest free screen on US equities
Stock RoverFree tier; Premium $29/mo, Premium Plus $49/mo, Ultimate $79/mo; 14-day trialDeep fundamental analysis and portfolio work
KoyfinFree tier; Plus $39/mo, Premium $79/mo; annual billing saves up to 30%Institutional-style data on a retail budget
ZacksFree tools; Premium and higher plans, check current pricingScreening on analyst estimate revisions

Pricing read from each vendor's own published pricing page, checked Sep 2026. 1 of 5 does not publish one; those entries say so rather than estimating.

Lowest published monthly priceTradingView$12.95Finviz$39.50Stock Rover$29Koyfin$39
Lowest monthly figure each vendor publishes, checked Sep 2026. A tilde marks a figure the vendor states approximately. Per-seat and usage charges can sit on top of it. 1 of 5 does not publish a comparable monthly price and is left out rather than estimated.
1

TradingView

Top Pick

Best for: Investors who want screening and charting in one tool

PricingFrom $12.95/mo billed annually (Essential); free plan ($0)

+Charting is best in class and the screener sits right beside it
+Genuinely usable free tier, and Essential at $12.95 removes most friction
+Huge library of community indicators and screening scripts
−Fundamental data is thinner than the dedicated fundamental screeners
−Free tier caps you at 2 indicators per chart and 3 price alerts
Visit TradingView →
2

Finviz

Best for: The fastest free screen on US equities

PricingFree tier with delayed data; Elite $39.50/mo or $299.95/yr

+Free tier is remarkably capable, with around 70 filters on US stocks
+Fastest interface here, results appear as you set filters
+The market heat map is the best quick read of sector rotation anywhere
−Free data is delayed, which rules it out for anything time-sensitive
−US-focused, with weak international coverage
Visit Finviz →
3

Stock Rover

Best for: Deep fundamental analysis and portfolio work

PricingFree tier; Premium $29/mo, Premium Plus $49/mo, Ultimate $79/mo; 14-day trial

+Deepest fundamental dataset here, with up to 10 years of history on higher tiers
+Screening, portfolio tracking and rebalancing in one place
+Excellent research reports and peer comparison tables
−Interface is dense and dated compared with TradingView
−Charting is functional rather than good
Visit Stock Rover →
4

Koyfin

Best for: Institutional-style data on a retail budget

PricingFree tier; Plus $39/mo, Premium $79/mo; annual billing saves up to 30%

+Data breadth and presentation feel professional rather than retail
+Strong global coverage including European and Asian listings
+Macro, credit and FX data alongside equities in one dashboard
−Screener is good but not the deepest here for fundamentals
−Learning curve is real if you have not used a terminal before
Visit Koyfin →
5

Zacks

Best for: Screening on analyst estimate revisions

PricingFree tools; Premium and higher plans, check current pricing

+Estimate revision data is its genuine differentiator and hard to get elsewhere at this price
+The Rank gives a starting shortlist without building a screen yourself
+Long track record and extensive published research
−Heavily oriented to one methodology, which you have to buy into
−Site design is cluttered and pushes upsells constantly
Visit Zacks →

What it is

A stock screener filters a universe of securities against criteria you define: valuation multiples, growth rates, margins, technical conditions, ownership, or analyst estimates.

Modern screeners layer on charting, backtesting (would this filter have produced anything historically), portfolio integration and alerting. The good ones let you save a screen and get notified when a new name qualifies rather than re-running it manually.

Why it matters

Without a screener you research the companies you happen to hear about, which is a well-documented way to end up owning whatever was in the news. A screen imposes a repeatable, explicit process: you write down what you are looking for, and the tool tells you which companies meet it.

The discipline matters more than the software. The best screener is the one whose filters match how you actually think about a business.

Key features to look for

Fundamental filter depth
How many financial metrics you can filter and combine, and how far back the history goes. Ten years of data separates real analysis from a snapshot.
Technical filters and charting
Price, volume, moving averages and pattern conditions, ideally on the same screen as the chart so you can eyeball a result immediately.
Backtesting
Running a screen against history to see what it would have surfaced. Not proof of anything, but it exposes filters that never match anything real.
Alerts on saved screens
Notification when a new company enters your screen. This is what turns a one-off search into an ongoing process.
Coverage and exchanges
Whether the tool covers the markets you invest in. Many strong US screeners thin out badly on European and Asian listings.

Pricing

TradingView, Finviz, Stock Rover and Koyfin all publish rate cards, checked on each vendor's pricing page in September 2026, while Zacks keeps its paid research behind named plans. TradingView lists a free plan, then Essential, Plus, Premium and Ultimate at a per-month rate billed annually.

Finviz Elite is $39.50 a month or $299.95 a year, Stock Rover Premium starts at $29 a month with a 14-day trial, and Koyfin Plus is $39 a month. No tool in this category is sold only on a custom quote. The cheapest credible entry is a free plan, and TradingView Essential is the lowest published paid price.

Costs jump at TradingView Ultimate and Stock Rover's Ultimate tiers, and Finviz's free tier carries delayed data, so Elite is the paid step when you need current quotes.

PlanPriceBest for
TradingView Free$01 chart per tab, 2 indicators per chart, 3 price alerts
TradingView Essential$12.95/mo billed annuallyEntry paid plan, annual savings
TradingView Plus$29.95/mo billed annuallyPaid plan, annual savings
TradingView Premium$59.95/mo billed annuallyPaid plan, annual savings
TradingView Ultimate$199.95/mo billed annuallyHighest listed plan, billed annually
Finviz FreeFreeFree tier with delayed data
Finviz Elite$39.50/mo or $299.95/yrReal-time quotes, backtesting and unlimited alerts
Stock Rover Premium$29/moEntry paid plan above the free tier, 14-day trial
Stock Rover Premium Plus$49/moDeeper research data and screening
Stock Rover Ultimate$79/moTop individual plan; Ultimate Pro is $149/mo
Koyfin Plus$39/mo10 years of financials and stock screeners
Koyfin Premium$79/moAdds portfolio analytics and custom formulas
Zacks PremiumCheck current pricingPaid research subscription
Zacks higher researchCheck current pricingHigher research subscriptions
Mistakes to avoid
×Treating screener output as a buy list. A screen produces a research queue. The output of a filter is a question, not an answer.
×Over-filtering until nothing qualifies. If a screen returns two companies, you have usually encoded a specific company rather than a strategy.
×Ignoring survivorship bias in backtests. Many datasets exclude delisted companies, which quietly makes every historical screen look better than reality.
×Paying for real-time data you do not need. If you hold positions for months, delayed quotes on a free tier cost you nothing.
Expert tips
→Start with three or four criteria, not fifteen. Add filters only when the result list is too long to read.
→Save your screens and set alerts rather than re-running them. The value compounds when new names arrive without you looking.
→Cross-check any screen result against the actual filings before acting. Screener data has errors, particularly on smaller listings.
→If you invest outside the US, test international coverage before subscribing. Several strong tools here thin out sharply beyond US listings.

The bottom line

If you think in charts, start with TradingView, and its free tier plus Essential at $12.95 a month billed annually covers most retail needs. If you think in financial statements, Stock Rover has the deepest data.

Finviz remains the fastest free screen on US equities and is worth keeping open regardless of what else you use, while Koyfin is the pick for global coverage. Whichever you choose, the screener is the cheap part; the research after it is the work.

Comparison of research tools only, not investment advice.

Frequently asked questions

What is the best free stock screener?
Finviz has the most capable free screener for US equities, with around 70 filters and results that update instantly, though its data is delayed. TradingView's free tier adds charting and global coverage but limits you to 2 indicators per chart and 3 price alerts. Koyfin's free tier is the most generous for data quality.
How much does a stock screener cost?
Many are usable free. Paid tiers typically run from about $13 to $60 a month for retail tools: TradingView starts at $12.95 for Essential and reaches $59.95 for Premium, billed annually. Dedicated fundamental platforms quote their own tiers, so check current pricing directly, and only pay for real-time data if your holding period actually requires it.
Is TradingView good for fundamental screening?
It is adequate rather than deep. TradingView's strength is charting and technical screening with global coverage; its fundamental filters cover the common ratios but lack the decade of history and hundreds of metrics that Stock Rover or Koyfin provide. Many investors run TradingView for charts and a second tool for fundamentals.
Can stock screeners backtest strategies?
Some can. Stock Rover offers backtesting on its higher tiers and Finviz Elite includes it, letting you see what a screen would have surfaced historically. Treat results carefully: many datasets suffer survivorship bias by excluding delisted companies, which makes historical screens look better than they were. Backtesting is not investment advice or a prediction.

Sources

Prices and plan details come from each vendor's own pricing page, re-checked by the Toolradar pricing tracker.

Related guides
Investing AppsBudgeting AppsCrypto Tax SoftwareTradingView Plans 2026: Is the Free Plan Enough?Koyfin ReviewFintech Statistics 2026

Some offers on this page may be paid placements or contain affiliate links.

Get the Finpresso brief

Free daily newsletter, read in 5 minutes.

Subscribe free